Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effectiveness of Baricitinib and Tocilizumab for Children with Systemic Juvenile Idiopathic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia France Italy Poland +1
  • Study of Afamelanotide for Patients with Erythropoietic Protoporphyria (EPP)

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium The Netherlands
  • Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Austria Denmark Finland France Germany Italy +3
  • Study on the Effectiveness and Safety of Crovalimab for Children with Atypical Hemolytic Uremic Syndrome (aHUS)

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium France Hungary Italy Poland Spain
  • Study on the Safety and Efficacy of Viltolarsen for Boys with Duchenne Muscular Dystrophy

    Not recruiting

    3 1 1
    Investigated Drugs:
    Czechia Greece Italy The Netherlands Norway Spain
  • Long-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Bulgaria France Germany Greece Hungary +7
  • Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Iceland
  • Study on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium Denmark France Italy The Netherlands Norway +2
  • Study on the Safety and Effects of AZD7789 for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Denmark France Italy Spain
  • Study on the Effects and Safety of Crovalimab for Adults and Adolescents with Atypical Hemolytic Uremic Syndrome (aHUS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Hungary Italy Poland +1